Related Experiment Video

Updated: Jun 6, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-kappaB signaling

Jian Liang1, Yasser Saad, Tianhua Lei

  • 1Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32816, USA.

The Journal of Experimental Medicine
|December 1, 2010
PubMed

Insights

Monocyte chemotactic protein-induced protein 1 (MCPIP1) deubiquitinates key inflammatory proteins, suppressing JNK and NF-κB signaling. MCPIP1 deficiency leads to fatal inflammatory syndrome in mice.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Macrophage-mediated inflammation is crucial in immune responses but requires tight regulation.
  • MCPIP1 (monocyte chemotactic protein-induced protein 1) is a CCCH Zn finger protein involved in controlling inflammatory responses.
  • The precise mechanism by which MCPIP1 regulates inflammation is not fully understood.

Purpose of the Study:

  • To elucidate the mechanism of action of MCPIP1 in regulating inflammatory signaling pathways.
  • To investigate the role of MCPIP1 in JNK and NF-κB activation.
  • To determine the deubiquitinating activity and functional domains of MCPIP1.

Main Methods:

  • Utilized MCPIP1-deficient mice to study inflammatory responses.
  • Analyzed macrophage and splenocyte gene expression and protein activation.
  • Performed in vitro deubiquitinating assays with purified MCPIP1.
  • Conducted sequence analysis and site-directed mutagenesis to identify functional domains.

Main Results:

  • MCPIP1 deficiency in mice resulted in spontaneous, fatal inflammatory syndrome.
  • MCPIP1-deficient macrophages and splenocytes exhibited heightened inflammatory gene expression and increased JNK and IκB kinase activation.
  • MCPIP1 was shown to remove ubiquitin from TRAF2, TRAF3, and TRAF6, thereby negatively regulating JNK and NF-κB.
  • Purified MCPIP1 demonstrated deubiquitinating activity, with identified deubiquitinating enzyme and ubiquitin association domains.

Conclusions:

  • MCPIP1 acts as a critical negative regulator of inflammatory signaling by deubiquitinating key components of the JNK and NF-κB pathways.
  • MCPIP1 is essential for preventing excessive inflammatory responses and maintaining immune homeostasis.
  • The deubiquitinating enzyme and ubiquitin association domains are crucial for MCPIP1's function in regulating inflammation.

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...